MNMD

Mind Medicine Inc

NASDAQ: MNMD · HEALTHCARE · BIOTECHNOLOGY

$15.02

+1.01% today

Updated 2026-01-14

Market cap

$1.46B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.98

Dividend yield

—

52W range

$5 – $15

Volume

1.9M

Market cap

$1.46B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.98

Dividend yield

—

52W range

$5 – $15

Volume

1.9M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →252 stocks currently score above 75

Price targets

Analyst target

$28.67

+90.88%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

3 Strong Buy10 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-29.57M

Key financials

Revenue Net Income Free Cash Flow

Metric	2021	2022	2023	2024	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-93.04M	$-56.80M	$-95.73M	$-108.68M	$-67.27M
EPS	—	—	—	—	$-1.98
Free cash flow	$-45.82M	$-50.14M	$-64.36M	$-79.13M	$-29.57M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
MNMD	$1.46B	20	4.3	3.0	5.0	5.0	—	Avoid
LLY	$994.92B	76	9.3	10.0	5.0	6.0	—	Strong Buy
JNJ	$640.02B	59	4.7	8.5	3.7	5.5	—	Buy
ABBV	$454.36B	73	6.7	8.5	4.0	5.0	-73.51%	Strong Buy
MRK	$355.10B	36	4.0	4.5	2.0	5.0	-77.20%	Hold
UNH	$340.27B	62	7.3	5.5	4.7	5.5	-15.43%	Buy

Smart narrative

Mind Medicine Inc trades at $15.02. Our Smart Value Score of 20/100 indicates the stock is weak.

Frequently asked questions

What is Mind Medicine Inc's stock price?

Mind Medicine Inc (MNMD) trades at $15.02.

Is Mind Medicine Inc overvalued?

Mind Medicine Inc carries a Smart Value Score of 20/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Mind Medicine Inc (MNMD)?

The 12-month analyst consensus target is $28.67, about 90.9% above the current $15.02. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-0.86%

Beta2.62

50D MA$13.48

200D MA$10.29

Shares out0.10B

Float0.10B

Short ratio—

Avg volume1.9M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

MNMD vs LLY →MNMD vs JNJ →MNMD vs ABBV →Stock screener →